Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Hematocrit levels and red blood cell indices in patients with nonalcoholic fatty liver disease.

Issa D, Albeldawi M, Lopez R, Alkhouri N.

Eur J Gastroenterol Hepatol. 2014 Mar;26(3):363-4. doi: 10.1097/MEG.0000000000000031. No abstract available.

PMID:
24463543
2.

Red cell distribution width in patients with nonalcoholic fatty liver disease.

Balta S, Demir M, Kurtoglu E, Demirkol S.

Eur J Gastroenterol Hepatol. 2014 Mar;26(3):361. doi: 10.1097/MEG.0000000000000017. No abstract available.

PMID:
24463540
3.

As an inexpensive and easily attainable marker red cell distribution width is associated with nonalcoholic fatty liver disease.

Tanoglu A, Karagöz E.

Eur J Gastroenterol Hepatol. 2014 Apr;26(4):494. doi: 10.1097/MEG.0000000000000055. No abstract available.

PMID:
24598386
4.

Is high RDW really closely associated with NAFLD?

Kayadibi H, Sertoglu E, Uyanik M.

Eur J Gastroenterol Hepatol. 2014 Jul;26(7):815. doi: 10.1097/MEG.0000000000000112. No abstract available.

PMID:
24901829
5.

Is hematocrit really associated with fibrosis in patients with nonalcoholic steatohepatitis?

Kayadibi H, Sertoglu E, Uyanik M.

Eur J Gastroenterol Hepatol. 2014 Jul;26(7):814-5. doi: 10.1097/MEG.0000000000000110. No abstract available.

PMID:
24901828
6.

Hematocrit is associated with fibrosis in patients with nonalcoholic steatohepatitis.

Li Y, Liu L, Wang B, Wang J, Chen D.

Eur J Gastroenterol Hepatol. 2014 Mar;26(3):332-8. doi: 10.1097/MEG.0000000000000015.

PMID:
24172912
7.

Changes in red blood cell size and red cell fragmentation during hemodialysis.

Booth J, Pinney J, Davenport A.

Int J Artif Organs. 2010 Dec;33(12):900-5.

PMID:
21186472
8.

[Red cell volume in alcoholic cirrhosis (author's transl)].

Jaulin F, Senecal P, Debray C.

Arch Fr Mal App Dig. 1974 Dec;63(8):631-7. French. No abstract available.

PMID:
4470398
9.

Red cell distribution width and nonalcoholic steatohepatitis.

Gulcan Kurt Y, Cayci T, Aydin FN, Agilli M.

World J Gastroenterol. 2014 Nov 21;20(43):16387-8. doi: 10.3748/wjg.v20.i43.16387.

10.

[Changes of liver fibrosis markers in nonalcoholic fatty liver disease patients].

Hong XF, Yu CH, Li YM.

Zhonghua Gan Zang Bing Za Zhi. 2007 Mar;15(3):229-30. Chinese. No abstract available.

PMID:
17407723
11.

Effects of liver disease on red blood cell acetaldehyde in alcoholics and non-alcoholics.

Uppal R, Rosman A, Hernández R, Baraona E, Lieber CS.

Alcohol Alcohol Suppl. 1991;1:323-6.

PMID:
1845555
12.

Comparison of haematological parameters in patients with non-alcoholic fatty liver disease and alcoholic liver disease.

Das SK, Mukherjee S, Vasudevan DM, Balakrishnan V.

Singapore Med J. 2011 Mar;52(3):175-81.

13.

Comparison of the effect of various amino acids upon the blood ammonia concentration of patients with liver disease.

Rudman D, Galambos JT, Smith RB 3rd, Salam AA, Warren WD.

Am J Clin Nutr. 1973 Sep;26(9):916-25. No abstract available.

PMID:
4727750
14.

Diagnosis of nonalcoholic fatty liver disease.

Yanai H, Morimoto M.

JAMA. 2003 Sep 24;290(12):1577; author reply 1578. No abstract available.

PMID:
14506111
15.

Serum fetuin A/α2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis.

Yilmaz Y, Yonal O, Kurt R, Ari F, Oral AY, Celikel CA, Korkmaz S, Ulukaya E, Ozdogan O, Imeryuz N, Avsar E, Kalayci C.

Ann Clin Biochem. 2010 Nov;47(Pt 6):549-53. doi: 10.1258/acb.2010.010169.

PMID:
20926473
16.

Elevated hematocrit in nonalcoholic fatty liver disease: a potential cause for the increased risk of cardiovascular disease?

Li G, Hu H, Shi W, Li Y, Liu L, Chen Y, Hu X, Wang J, Gao J, Yin D.

Clin Hemorheol Microcirc. 2012;51(1):59-68. doi: 10.3233/CH-2011-1509.

PMID:
22240370
17.

[Rheological and biochemical behavior of the red blood cell in liver cirrhosis].

Vives Corrons JL, Caballería J, Berga L, Jou JM, Dolz JM, Ester A, Pastor C, Coca L, Piera C, Aguilar JL.

Sangre (Barc). 1982;27(4-B):629-42. Spanish. No abstract available.

PMID:
7157137
18.

[Erythrocyte filterability and relative viscosity in liver cirrhosis and chronic hepatitis].

Mares M, Visentin I, Radossi P, Boeri G, Girolami A.

Clin Ter. 1989 May 31;129(4):243-59. Italian.

PMID:
2527119
19.

Differentiation of nonalcoholic from alcoholic steatohepatitis: are routine laboratory markers useful?

Kazemi-Shirazi L, Veloso MP, Frommlet F, Steindl-Munda P, Wrba F, Zehetmayer S, Marsik C, Ferenci P.

Wien Klin Wochenschr. 2008;120(1-2):25-30. doi: 10.1007/s00508-007-0921-1.

PMID:
18239988
20.

[Erythrocyte filtrability and cirrhosis (author's transl)].

Hanss M, Paraf A.

Pathol Biol (Paris). 1981 Oct;29(8):496-8. French. No abstract available.

PMID:
7029429
Items per page

Supplemental Content

Support Center